Cell Surface Vimentin Positive Circulating Tumor Cell-Based Relapse Prediction in a Long-Term Longitudinal Study of Post-Remission Neuroblastoma Patients

Neuroblastoma (NB) is a deadly childhood disease that carries a 50% chance of relapse for anyone in remission and similar level of 5-year survival. We investigated the value of our proprietary approach – cell surface vimentin (CSV) positive circulating tumor cells (CTC) to monitor treatment response...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Cancer
Main Authors: Batth, Izhar S., Dao, Long, Satelli, Arun, Mitra, Abhisek, Yi, Sofia, Noh, Hyangsoon, Li, Heming, Brownlee, Zachary, Zhou, Shouhao, Bond, Jeffrey, Wang, Jing, Gill, Jonathan, Sholler, Giselle S., Li, Shulin
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7839076/
https://ncbi.nlm.nih.gov/pubmed/32506485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.33140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados